Information updates

Parliamentary Inquiry into Allergies and Anaphylaxis

19 November 2019

There were two hearings this week for the Parliamentary Inquiry into Allergies and Anaphylaxis, in Melbourne on Monday 18th November 2019 (10am-5pm) and in Sydney on Tuesday 19th November 2019 (9.30-4.30pm). Hansard records of the hearings will soon be on the APH website

ASCIA lodged a submission to the Inquiry on 24 October 2019 and an opening statement was presented by the ASCIA President, Dr Brynn Wainstein at the Tuesday hearing, conducted by the House of Representatives Standing Committee on Health, Aged Care and Sport committee. Both documents can be viewed on the ASCIA website allergy.org.au/about-ascia/ascia-initiatives#collab
 

More than twenty ASCIA members were involved as witnesses in the Sydney and Melbourne hearings, including:

  • Four ASCIA Council members (Dr Lara Ford, Dr Preeti Joshi, Dr Brynn Wainstein and Dr Melanie Wong).
  • Four past ASCIA Presidents - Professor Tony Basten AO, Professor Jo Douglass, Professor Connie Katelaris AM and Dr Melanie Wong.

Two ASCIA staff members (Jill Smith, ASCIA CEO and Sandra Vale, National Allergy Strategy Manager) were also involved as witnesses for the Sydney hearing. 

The ASCIA submission focuses on the following ten key issues: 

  1. Support is required for quality allergy and anaphylaxis educational and training resources for patients, carers and health professionals.
  2. Support is required for quality, evidence-based allergy and anaphylaxis education and training for all health professionals.
  3. Improved access to timely, equitable and quality care for patients with allergic disease is needed.
  4. Improved access to skin testing reagents for allergy diagnosis by clinical immunology/allergy specialists is needed.
  5. A specific food allergen challenge MBS item number is needed.
  6. A specific drug allergen challenge MBS item number is needed.
  7. Improved access to evidence-based and cost-effective treatments is needed.
  8. Support is required for further research into all allergic diseases.
  9. Support is required for further research into food allergy treatments including oral immunotherapy.
  10. National anaphylaxis and drug allergy registers do not exist.

Individuals or organisations wish to make a submission the deadline has recently been extended to Friday 29 November 2019 and hearings will be held in other cities.

For details go to aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport